Avidity Partners Management as of Sept. 30, 2023
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 83 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | 4.4 | $109M | 2.1M | 52.80 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 4.2 | $103M | 798k | 129.44 | |
| Becton, Dickinson and (BDX) | 3.0 | $74M | 287k | 258.53 | |
| Neurocrine Biosciences (NBIX) | 3.0 | $73M | 652k | 112.50 | |
| McKesson Corporation (MCK) | 2.9 | $72M | 166k | 434.85 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.6 | $65M | 967k | 67.17 | |
| Tenet Healthcare Corp Com New (THC) | 2.6 | $64M | 964k | 65.89 | |
| Cigna Corp (CI) | 2.4 | $59M | 208k | 286.07 | |
| Ideaya Biosciences (IDYA) | 2.3 | $58M | 2.1M | 26.98 | |
| UnitedHealth (UNH) | 2.3 | $57M | 112k | 504.19 | |
| Sarepta Therapeutics (SRPT) | 2.2 | $55M | 450k | 121.22 | |
| Humana (HUM) | 2.2 | $54M | 110k | 486.52 | |
| Arvinas Ord (ARVN) | 2.1 | $51M | 2.6M | 19.64 | |
| Acadia Healthcare (ACHC) | 2.0 | $50M | 715k | 70.31 | |
| Karuna Therapeutics Ord | 2.0 | $49M | 287k | 169.09 | |
| Regeneron Pharmaceuticals (REGN) | 1.9 | $48M | 58k | 822.96 | |
| Zoetis Cl A (ZTS) | 1.8 | $46M | 262k | 173.98 | |
| Immunovant (IMVT) | 1.8 | $45M | 1.2M | 38.39 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.8 | $44M | 777k | 57.00 | |
| Danaher Corporation (DHR) | 1.8 | $44M | 177k | 248.10 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.7 | $42M | 2.1M | 20.06 | |
| Intra Cellular Therapies (ITCI) | 1.7 | $42M | 801k | 52.09 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $41M | 2.8M | 14.52 | |
| Eli Lilly & Co. (LLY) | 1.6 | $40M | 75k | 537.13 | |
| Natera (NTRA) | 1.6 | $40M | 899k | 44.25 | |
| Argenx Se Sponsored Adr (ARGX) | 1.6 | $40M | 81k | 491.63 | |
| Surgery Partners (SGRY) | 1.6 | $39M | 1.3M | 29.25 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.6 | $39M | 558k | 69.48 | |
| Vaxcyte (PCVX) | 1.6 | $39M | 756k | 50.98 | |
| Blueprint Medicines (BPMC) | 1.5 | $38M | 752k | 50.22 | |
| Akero Therapeutics (AKRO) | 1.5 | $37M | 739k | 50.58 | |
| Mirum Pharmaceuticals (MIRM) | 1.5 | $36M | 1.1M | 31.60 | |
| Privia Health Group (PRVA) | 1.4 | $36M | 1.5M | 23.00 | |
| Dex (DXCM) | 1.4 | $35M | 378k | 93.30 | |
| Biohaven (BHVN) | 1.3 | $33M | 1.3M | 26.01 | |
| Rocket Pharmaceuticals (RCKT) | 1.3 | $33M | 1.6M | 20.49 | |
| Amylyx Pharmaceuticals (AMLX) | 1.3 | $32M | 1.8M | 18.31 | |
| ImmunoGen | 1.2 | $30M | 1.9M | 15.87 | |
| Biogen Idec (BIIB) | 1.2 | $30M | 115k | 257.01 | |
| Caribou Biosciences (CRBU) | 1.2 | $29M | 6.1M | 4.78 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.2 | $29M | 1.1M | 26.87 | |
| Hca Holdings (HCA) | 1.1 | $28M | 115k | 245.98 | |
| Neumora Therapeutics (NMRA) | 1.0 | $25M | 1.8M | 14.11 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.0 | $25M | 500k | 50.42 | |
| Universal Hlth Svcs CL B (UHS) | 0.9 | $23M | 182k | 125.73 | |
| Curevac N V (CVAC) | 0.9 | $21M | 3.1M | 6.83 | |
| Axsome Therapeutics (AXSM) | 0.8 | $21M | 297k | 69.89 | |
| Ultragenyx Pharmaceutical (RARE) | 0.8 | $19M | 544k | 35.65 | |
| Prothena Corp SHS (PRTA) | 0.7 | $18M | 382k | 48.25 | |
| Revolution Medicines (RVMD) | 0.7 | $18M | 657k | 27.68 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.7 | $18M | 610k | 29.74 | |
| Immunocore Hldgs Ads (IMCR) | 0.7 | $18M | 348k | 51.90 | |
| Roivant Sciences SHS (ROIV) | 0.7 | $18M | 1.5M | 11.68 | |
| An2 Therapeutics (ANTX) | 0.7 | $18M | 1.1M | 16.08 | |
| Phathom Pharmaceuticals (PHAT) | 0.7 | $17M | 1.6M | 10.37 | |
| Dianthus Therapeutics (DNTH) | 0.7 | $17M | 1.2M | 13.67 | |
| Fusion Pharmaceuticals (FUSN) | 0.6 | $15M | 5.8M | 2.60 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.6 | $14M | 643k | 21.83 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.5 | $14M | 830k | 16.30 | |
| Ventyx Biosciences (VTYX) | 0.5 | $12M | 355k | 34.73 | |
| Intellia Therapeutics (NTLA) | 0.5 | $12M | 379k | 31.62 | |
| Travere Therapeutics (TVTX) | 0.5 | $12M | 1.3M | 8.94 | |
| Schrodinger (SDGR) | 0.5 | $11M | 399k | 28.27 | |
| Karyopharm Therapeutics (KPTI) | 0.4 | $11M | 8.3M | 1.34 | |
| Rayzebio | 0.4 | $11M | 500k | 22.20 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $11M | 321k | 34.16 | |
| Pacific Biosciences of California (PACB) | 0.3 | $8.6M | 1.0M | 8.35 | |
| Ac Immune Sa SHS (ACIU) | 0.3 | $8.5M | 3.0M | 2.85 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.3 | $7.8M | 350k | 22.35 | |
| Alpine Immune Sciences (ALPN) | 0.3 | $7.5M | 657k | 11.45 | |
| Kezar Life Sciences (KZR) | 0.3 | $7.2M | 6.0M | 1.19 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.3 | $6.2M | 1.6M | 3.95 | |
| Gritstone Oncology Ord (GRTS) | 0.2 | $4.7M | 2.7M | 1.72 | |
| Alphatec Hldgs Com New (ATEC) | 0.2 | $4.0M | 309k | 12.97 | |
| Nanostring Technologies (NSTGQ) | 0.2 | $4.0M | 2.3M | 1.72 | |
| Verve Therapeutics (VERV) | 0.2 | $3.8M | 285k | 13.26 | |
| Compass Therapeutics (CMPX) | 0.1 | $3.2M | 1.6M | 1.97 | |
| Altimmune Com New (ALT) | 0.1 | $3.0M | 1.2M | 2.60 | |
| Scynexis Com New (SCYX) | 0.1 | $3.0M | 1.3M | 2.28 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $2.4M | 1.2M | 2.05 | |
| Century Therapeutics (IPSC) | 0.1 | $2.2M | 1.1M | 2.00 | |
| Caremax Com Cl A | 0.1 | $1.3M | 636k | 2.12 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $9.0k | 90k | 0.10 |
